These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26170557)

  • 21. Ethylene diamine tetramethylene phosphonic acid labeled with various β(-)-emitting radiometals: labeling optimization and animal biodistribution.
    Sohaib M; Ahmad M; Jehangir M; Perveen A
    Cancer Biother Radiopharm; 2011 Apr; 26(2):159-64. PubMed ID: 21510750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimated human absorbed dose of a new (153)Sm bone seeking agent based on biodistribution data in mice: Comparison with (153)Sm-EDTMP.
    Yousefnia H; Zolghadri S
    Phys Med; 2015 Nov; 31(7):714-9. PubMed ID: 26095757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic, Dosimetry and Toxicity Study of ¹⁷⁷Lu-EDTMP in Patients: Phase 0/I study.
    Bal C; Arora G; Kumar P; Damle N; Das T; Chakraborty S; Banerjee S; Venkatesh M; Zaknun JJ; Pillai MR
    Curr Radiopharm; 2016; 9(1):71-84. PubMed ID: 25771371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ¹⁷⁷Lu-EDTMP for treatment of bone pain in patients with disseminated skeletal metastases.
    Shinto AS; Shibu D; Kamaleshwaran KK; Das T; Chakraborty S; Banerjee S; Thirumalaisamy P; Das P; Veersekar G
    J Nucl Med Technol; 2014 Mar; 42(1):55-61. PubMed ID: 24503346
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Timing and optimized acquisition parameters for the whole-body imaging of ¹⁷⁷Lu-EDTMP toward performing bone pain palliation treatment.
    Liu C; Brašić JR; Liu X; Li H; Xiang X; Luo Z; Wang Y; Kuai D; Zhang G; Zaknun JJ
    Nucl Med Commun; 2012 Jan; 33(1):90-6. PubMed ID: 22001721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (177)Lu-labelled macrocyclic bisphosphonates for targeting bone metastasis in cancer treatment.
    Bergmann R; Meckel M; Kubíček V; Pietzsch J; Steinbach J; Hermann P; Rösch F
    EJNMMI Res; 2016 Dec; 6(1):5. PubMed ID: 26780082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Internal dosimetry studies of
    Shirmardi SP; Saniei E; Das T; Noorvand M; Erfani M; Bagheri R
    Appl Radiat Isot; 2020 Dec; 166():109396. PubMed ID: 32889376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. (175)Yb-TTHMP as a good candidate for bone pain palliation and substitute of other radiopharmaceuticals.
    Safarzadeh L
    Indian J Nucl Med; 2014 Jul; 29(3):135-9. PubMed ID: 25210277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 177Lu-EDTMP: a viable bone pain palliative in skeletal metastasis.
    Chakraborty S; Das T; Banerjee S; Balogh L; Chaudhari PR; Sarma HD; Polyák A; Máthé D; Venkatesh M; Janoki G; Pillai MR
    Cancer Biother Radiopharm; 2008 Apr; 23(2):202-13. PubMed ID: 18454689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 177Lu-EDTMP: a potential therapeutic bone agent.
    Ando A; Ando I; Tonami N; Kinuya S; Kazuma K; Kataiwa A; Nakagawa M; Fujita N
    Nucl Med Commun; 1998 Jun; 19(6):587-91. PubMed ID: 10234664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative studies of 177Lu-EDTMP and 177Lu-DOTMP as potential agents for palliative radiotherapy of bone metastasis.
    Chakraborty S; Das T; Sarma HD; Venkatesh M; Banerjee S
    Appl Radiat Isot; 2008 Sep; 66(9):1196-205. PubMed ID: 18372188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and biological evaluation of 188Re-ethylenediamine-N,N,N',N'-tetrakis(methylene phosphonic acid) as a potential agent for bone pain palliation.
    Oh SJ; Won KS; Moon DH; Cheon JH; Ha HJ; Jeong JM; Lee HK
    Nucl Med Commun; 2002 Jan; 23(1):75-81. PubMed ID: 11748441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Study of Bone Surface Absorbed Dose in Treatment of Bone Metastases via Selected Radiopharmaceuticals: Using MCNP4C Code and Available Experimental Data.
    Bagheri R; Afarideh H; Maragheh MG; Shirmardi SP; Samani AB
    Cancer Biother Radiopharm; 2015 May; 30(4):174-81. PubMed ID: 25775234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Samarium-153 EDTMP therapy of disseminated skeletal metastasis.
    Turner JH; Martindale AA; Sorby P; Hetherington EL; Fleay RF; Hoffman RF; Claringbold PG
    Eur J Nucl Med; 1989; 15(12):784-95. PubMed ID: 2483138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the [(153)Sm]Sm-EDTMP pharmacokinetics and estimation of radiation absorbed dose on an individual basis.
    Vigna L; Matheoud R; Ridone S; Arginelli D; Della Monica P; Rudoni M; Inglese E; Brambilla M
    Phys Med; 2011 Jul; 27(3):144-52. PubMed ID: 20864370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human Absorbed Dose Evaluation of [177Lu]Lu-IBA as a Bone Palliative Candidate.
    Ranjbar H; Pourhabib Z
    Nuklearmedizin; 2021 Oct; 60(5):375-380. PubMed ID: 34102691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel developed HPLC analyses of [
    Eryilmaz K; Bakar HE; Kilbas B
    J Labelled Comp Radiopharm; 2022 Jun; 65(7):178-186. PubMed ID: 35466456
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Voxel-Based Dosimetry of Iron Oxide Nanoparticle-Conjugated
    Gupta A; Shin JH; Lee MS; Park JY; Kim K; Kim JH; Suh M; Park CR; Kim YJ; Song MG; Jeong JM; Lee DS; Lee YS; Lee JS
    Mol Pharm; 2019 Apr; 16(4):1498-1506. PubMed ID: 30821463
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.